Welcome to Medications.com

GSK shelves ambitious growth plans, cuts jobs - News & Observer

End of 2008: Migraine pill Imitrex will lose patent protection. Treximet, if approved, would replace Imitrex. GlaxoSmithKline is forfeiting $1.4 million in ...

http://www.newsobserver.com/busin... | Posted: Fri Feb 15 02:53:00 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea